Clinical evaluation of cephaloridine.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002509:Cephaloridine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007239:Infections / Q000188:drug therapy*; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy
D002509:Cephaloridine